139 related articles for article (PubMed ID: 11920924)
1. Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine.
Meshulam Y; Cohen G; Chapman S; Alkalai D; Levy A
J Appl Toxicol; 2001 Dec; 21 Suppl 1():S75-8. PubMed ID: 11920924
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea-pigs.
Meshulam Y; Davidovici R; Wengier A; Levy A
J Appl Toxicol; 1995; 15(4):263-6. PubMed ID: 7594194
[TBL] [Abstract][Full Text] [Related]
3. Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig.
Wetherell J; Hall T; Passingham S
Neurotoxicology; 2002 Sep; 23(3):341-9. PubMed ID: 12387361
[TBL] [Abstract][Full Text] [Related]
4. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus).
Muggleton NG; Bowditch AP; Crofts HS; Scott EA; Pearce PC
Psychopharmacology (Berl); 2003 Mar; 166(3):212-20. PubMed ID: 12589520
[TBL] [Abstract][Full Text] [Related]
5. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats.
Choi EK; Park D; Yon JM; Hur GH; Ha YC; Che JH; Kim J; Shin S; Jang JY; Hwang SY; Seong YH; Kim DJ; Kim JC; Kim YB
Eur J Pharmacol; 2004 Nov; 505(1-3):83-91. PubMed ID: 15556140
[TBL] [Abstract][Full Text] [Related]
6. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
Wetherell JR
J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
[TBL] [Abstract][Full Text] [Related]
7. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs.
Kim WS; Cho Y; Kim JC; Huang ZZ; Park SH; Choi EK; Shin S; Nam SY; Kang JK; Hwang SY; Kim YB
Eur J Pharmacol; 2005 Nov; 525(1-3):135-42. PubMed ID: 16256978
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of two scopolamine and physostigmine pretreatment regimens against nerve agent poisoning in the dog.
Bonhage MR; Chilcoat CD; Li Q; Melendez V; Flournoy WS
J Vet Pharmacol Ther; 2009 Apr; 32(2):146-53. PubMed ID: 19290944
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized scopolamine protects against microinstillation inhalation toxicity to sarin in guinea pigs.
Che MM; Chanda S; Song J; Doctor BP; Rezk PE; Sabnekar P; Perkins MW; Sciuto AM; Nambiar MP
Toxicol Mech Methods; 2011 Jul; 21(6):463-72. PubMed ID: 21651338
[TBL] [Abstract][Full Text] [Related]
10. Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys.
Cho Y; Kim WS; Hur GH; Ha YC
Environ Toxicol Pharmacol; 2012 Jan; 33(1):1-8. PubMed ID: 22051905
[TBL] [Abstract][Full Text] [Related]
11. Prevention of soman toxicity after the continuous administration of physostigmine.
Lim DK; Ito Y; Yu ZJ; Hoskins B; Ho IK
Pharmacol Biochem Behav; 1988 Nov; 31(3):633-9. PubMed ID: 3251247
[TBL] [Abstract][Full Text] [Related]
12. Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine.
Barak S; Weiner I
Psychopharmacology (Berl); 2010 Apr; 209(2):175-84. PubMed ID: 20179909
[TBL] [Abstract][Full Text] [Related]
13. Physostigmine-loaded liposomes for extended prophylaxis against nerve agent poisoning.
Park JH; Lee JY; Kim KT; Joe HE; Cho HJ; Shin YK; Kim DD
Int J Pharm; 2018 Dec; 553(1-2):467-473. PubMed ID: 30389473
[TBL] [Abstract][Full Text] [Related]
14. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers.
Dukoff R; Wilkinson CW; Lasser R; Friz J; Conway A; Bahro M; Peskind ER; Sunderland T
Biol Psychiatry; 1999 Jul; 46(2):189-95. PubMed ID: 10418693
[TBL] [Abstract][Full Text] [Related]
15. Stress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs.
Philippens IH; Joosen MJ; Vanwersch RA
Pharmacol Biochem Behav; 2005 Sep; 82(1):125-32. PubMed ID: 16126267
[TBL] [Abstract][Full Text] [Related]
16. Comparative physiology and efficacy of atropine and scopolamine in sarin nerve agent poisoning.
Cornelissen AS; Klaassen SD; van Groningen T; Bohnert S; Joosen MJA
Toxicol Appl Pharmacol; 2020 Jun; 396():114994. PubMed ID: 32251685
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of equine butyrylcholinesterase in inhalation intoxication of rats with sarin: determination of blood and brain cholinesterase activities.
Sevelová L; Bajgar J; Saxena A; Doctor BP
Inhal Toxicol; 2004 Jul; 16(8):531-6. PubMed ID: 15204744
[TBL] [Abstract][Full Text] [Related]
18. Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
Lallement G; Foquin A; Dorandeu F; Baubichon D; Carpentier P
Drug Chem Toxicol; 2001 May; 24(2):165-80. PubMed ID: 11360433
[TBL] [Abstract][Full Text] [Related]
19. Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects.
Philippens IH; Busker RW; Wolthuis OL; Olivier B; Bruijnzeel PL; Melchers BP
Pharmacol Biochem Behav; 1998 Apr; 59(4):1061-7. PubMed ID: 9586868
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of antidotal treatment against sarin poisoning: the superiority of benactyzine and caramiphen.
Raveh L; Rabinovitz I; Gilat E; Egoz I; Kapon J; Stavitsky Z; Weissman BA; Brandeis R
Toxicol Appl Pharmacol; 2008 Feb; 227(1):155-62. PubMed ID: 18320638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
